U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06896045) titled 'Multicenter Study Evaluating the Relationship Between Perceived Daily Stress Level and Glycemic Level in Subjects with Type 1 Diabetes' on Feb. 28.

Brief Summary: Type 1 diabetes (T1D) affects around 200,000 people in France. The only treatment is insulin, administered either by multiple injections, by pump alone or, more recently, by automated insulin delivery systems (AIDs), which have resulted in a very significant improvement in glycaemic control and quality of life. These closed-loop (CL) devices are capable of effectively regulating the conventional factors associated with glycaemic disturbance, namely dietary intake and phys...